DS
WGS icon

David Shaw’s GeneDx Holdings WGS Stock Holding History

David Shaw’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Buy
38,200
+6,900
+22% +$392K ﹤0.01% 2973
2026
Q1 		$2.01M Buy
31,300
+14,800
+90% +$1.35M ﹤0.01% 2904
2025
Q4 		$2.15M Sell
16,500
-16,700
-50% -$2.29M ﹤0.01% 3001
2025
Q3 		$3.58M Buy
33,200
+1,000
+3% +$109K ﹤0.01% 2510
2025
Q2 		$2.97M Buy
32,200
+26,200
+437% +$2.06M ﹤0.01% 2435
2025
Q1 		$531K Buy
6,000
+3,100
+107% +$269K ﹤0.01% 3474
2024
Q4 		$223K Buy
+2,900
New +$203K ﹤0.01% 4037

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

David Shaw's WGS Position: Q2 2026 in Review

David Shaw increased its GeneDx Holdings (WGS) stake by 106% in Q2 2026, buying an estimated $1.14M and bringing the position to 38,877 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2952.

David Shaw first reported a position in WGS in Q1 2021 and has held it in 15 quarters since. The position peaked at $35.4M in Q1 2025. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • David Shaw held 38,877 shares of GeneDx Holdings worth $2.67M as of Q2 2026.
  • David Shaw bought 19,974 GeneDx Holdings shares in Q2 2026, an estimated $1.14M.
  • GeneDx Holdings made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2952 holding.
  • David Shaw first reported a position in GeneDx Holdings in Q1 2021 and has held it in 15 quarters since.
  • David Shaw's GeneDx Holdings position peaked at $35.4M in Q1 2025.
  • 222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.